10.1093/jnci/djac015 - Randomized Trial of First-Line Tyrosi...

This document has been corrected

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer

10.1093/jnci/djac015

Published Online: 2022-01-30

Journal: JNCI: Journal of the National Cancer Institute•Publisher: Oxford University Press (OUP)

Authors: Bang-Xian Tan•Fan-Xin Zeng•Gang Feng•Hai-Xia Pan•Han-Song Bai•Hao Liu•Kai Zhang•Ke Xie•Lan Yang•Liang-Fu Han•Lin Jia•Ming Zeng•Ming-Xiu Zhou•Rui Ao•Rui-Lian Yu•Si-Min Li•Vivek Verma•Wei Tian•Xiao-Shan Wang•Xin-Bao Hao•Xing Luo•Xue Cheng•Xue-Qiang Zhu•Yan Guo•Yi-Feng Bai•Ying Deng•Ying-Yi Liu•You Lu•You-Yu Wang•Yue-Mei Sun•Zi-Can Zhang

This document has been corrected

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer

10.1093/jnci/djac015

Published Online: 2022-01-30

Journal: JNCI: Journal of the National Cancer Institute

NOW

2022-04-01•Expression of concern(s)

Expression of Concern to: Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer

10.1093/jnci/djac065

Reasons: Concerns/Issues about Authorship/Affiliation • Concerns/Issues about Referencing/Attributions • Investigation by Journal/Publisher

* information provided by RetractionWatch

2022-04-01•Expression of concern(s)

10.1093/jnci/djac065

Reasons: Concerns/Issues about Authorship/Affiliation • Concerns/Issues about Referencing/Attributions • Investigation by Journal/Publisher

* information provided by RetractionWatch

2022-01-30•Published

2022-04-01•Expression of concern(s)

Expression of Concern to: Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer

10.1093/jnci/djac065

Reasons: Concerns/Issues about Authorship/Affiliation • Concerns/Issues about Referencing/Attributions • Investigation by Journal/Publisher

* information provided by RetractionWatch

This document has been corrected

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer

10.1093/jnci/djac015

Published Online: 2022-01-30

Journal: JNCI: Journal of the National Cancer Institute•Publisher: Oxford University Press (OUP)